Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AXITINIB vs AZELASTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AXITINIB vs AZELASTINE: Safety Overview

Metric AXITINIB AZELASTINE
Total FAERS Reports 15,863 5,896
Deaths Reported 3,141 12
Death Rate 19.8% 0.2%
Hospitalizations 4,050 89
Average Patient Age 65.5 yrs 62.6 yrs
% Female Patients 29.4% 67.1%
FDA Approval Date Jan 27, 2012 Apr 30, 2009
Manufacturer Pfizer Laboratories Div Pfizer Inc A-S Medication Solutions
Route ORAL NASAL
Marketing Status Prescription Discontinued